Our Company
ESG Management
Material Issues
ESG Performance
ESG Factbook
APPENDIX
CEO Message
Company Overview
Hanmi Pharm Business Model
2025 Performance
Business Growth & Innovation
R&D Management
Lim Sung Ki Foundation
Hanmi Pharm ESG Management
2025 Materiality Assessment
Stakeholder Communication
Material Issue 1Pharmaceutical Product Safety Assurance
Material Issue 2Strengthening Ethical & Compliance Management
Material Issue 3Strengthening Workplace Health & Safety
Material Issue 4Responsible Supply Chain Management
Material Issue 5Information Security including Personal Information Protection
GOVERNANCE
Corporate Governance
Risk Management
ENVIRONMENTAL
Climate Change Response & Environmental Management
Biodiversity Conservation
SOCIAL
Human Rights Management
Human Capital
Welfare & Culture
Responsible Marketing
Social Contribution
Financial Performance
EHS Management Performance
Human-oriented Management Performance
Reporting Framework
Reporting Scope & Verification
Current Status of Membership of Domestic & Overseas Associations
ESG Policies
ESG Assessment
Report Archive
HANMI SUSTAINABILITY
2025-26 Hanmi pharmaceutical ESG Report
health LIFE, sustainable FUTURE